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Abstract
The cost of cancer is vastly different across the globe, which inevitably results
in decreased access to lifesaving medication and treatment for individuals who
cannot afford the rising costs. This conflict poses a questionable violation of the
international human right to health care when a patient in one country has access
to a lifesaving drug, but a patient in another country is refused the same treat-
ment. While several governments across the globe have refuted the ideology be-
hind the right to health, governments that recognize a right to health should act as
models for improved access to care and decreased direct costs for patients. Gov-
ernments across the globe are called to look to their respective human rights
treaties, modeled by the World Health Organization, to effectively analyze a pos-
sible human rights violation and come together to create equality in the access to
cancer treatments across the world.
I. Introduction
"Of all the forms of inequality, injustice in health care is the most shocking
and inhumane."
-Dr. Martin Luther King, Jr.
Economists have recently endeavored to measure and rank the best countries
to be born in, using a quality-of-life index that measures the opportunities that
each country provides for its children to live a healthy and prosperous life.' child
born in the study's top ranked country is said to have "won the lottery of life"
* B.A., The Ohio State University, 2012; J.D., Loyola University of Chicago School of Law, May
2015.
1 The Lottery of Life, THE EcoNoMIsT (Nov. 21, 2012), http://www.economist.com/news/21566430-
where-be-born-2013-lottery-life.
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because he or she will have the best opportunity for a healthy and prosperous
life. 2 The same idea can be applied to those born in countries that guarantee
access to lifesaving health care. If a child is born in a country that recognizes the
right to health or the highest attainable standard of life, he will be guaranteed
access to the best treatment and medicine despite inability to pay. He has "won
the lottery." However, if a child is born in a country that does not recognize the
right to health, he will not be guaranteed access to lifesaving medicine should he
ever need it, he may be turned away from hospitals and medical providers, and he
may not be given a chance to survive. He has lost.
It is difficult to define the right to health. Human rights activists often have a
difficult time determining what the phrase encompasses, where the line is drawn
between a right and a privilege, and who is entitled to the right. While interna-
tional meetings to negotiate and draft documents defining the global right to
health have made significant strides toward universal health care or a right to
health for all individuals, not all countries have adopted the documents or fully
accepted the ideology. 3 As a result, a significant portion of the world does not
have a meaningful right to health. Ultimately, those living in countries that do not
recognize a right to health pay exuberant amounts for lifesaving care. Approxi-
mately 150 million people across the world suffer from financial devastation fol-
lowing necessary medical care, and 100 million people are forced below the
poverty level as a result of health care expenditure.4 Specifically, the cost cancer
patients incur for cancer treatment leaves many completely unable to meet their
financial obligations or worse - left without care because they are unable to af-
ford it.5
This article will first analyze several important international documents that
have addressed the basic human right to health. Each one builds off the former
and further defines the rights, services, and advancements in technology all
humans are entitled to in order to sustain a healthy well-being.6 Next, this article
will determine what effect a right to health and increased access to cancer treat-
ment can have on the global economic cost of cancer. Furthermore, the value of
prevention and detection services will be addressed as a method for reversing the
global economic cost of cancer. Third, this article will compare France's ap-
proach to the right to health and the resulting access to care and cost of treat-
ments for cancer patients with the United States' approach, access, and cost for
cancer treatment. Lastly, this article will propose heightened responsibilities for
the United States to address its stance on the right to health in order to reduce or
reverse the epidemiological and economic implications of cancer.
2 Id.
3 The Right to Health, WORLD HEALTH ORG. (last updated Nov. 2013), www.who.int/mediacentre/
factsheets/fs323/en/ (universal health care is a health system which provides health care and financial
protection to all citizens).
4 Id.
5 See THu GLOBAL ECONOMIC COST OF CANCER, AM. CANCER Soc'y & LIVESTRONG 2, 4-5 (2011),
available at http://www.cancer.org/acs/groups/content/@ internationalaffairs/documents/document/acspc-
026203.pdf.
6 The Right to Health, supra note 3.
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II. Background
Several key international treaties, reports, and documents have addressed the
universal right to health-each defining the right differently, but with the same
focus on the citizen's well-being. This section will first discuss the United Na-
tion's ("UN") Universal Declaration of Human Rights, established in 1948,
which was the first treaty to internationally recognize the right to health.7 Sec-
ond, this section will discuss the significant creation of the World Health Organi-
zation and its Constitution, which addresses an individual's standard of health.8
Lastly, this section will look at the International Covenant on Economic, Social,
and Cultural Rights ("ICESCR"), a human rights treaty passed by the UN in 1966
in order to set out goals for achieving the international right to health.9
The concept of an international right to health was introduced in what would
become the Universal Declaration of Human Rights during the UN's inaugural
meetings in 1946.10 The UN was created immediately after World War II to
promote peace between member states and to ensure that its citizens' basic
human rights would be protected." Among the drafters and member states were:
China, the USSR, France, the United States, United Kingdom, Lebanon, Austra-
lia, Chile, and Canada as well as forty-one other developing nations.' 2 In a time
of international turmoil, the member states, all of which were comprised of dif-
ferent political, cultural, and religious backgrounds, agreed to draft the Universal
Declaration of Human Rights to serve as an "International Bill of Human
Rights."l 3 The UN eventually adopted the Declaration on December 10, 1948.14
Fundamental themes of the document are the equal rights of men and women
across the world, as well as the promotion of social progress and a better standard
of life.' 5 Article 25 of the Declaration specifically addresses an individual's right
to health.1 6 The Declaration indicates that all individuals are entitled to an ade-
quate standard of living in order to maintain their health and well-being.'7 An
individual's standard of living is measured in terms of necessary food, clothing,
7 Universal Declaration of Human Rights, G.A. Res. 217 (1II) A, U.N. Doc. AIRES/217(III), at art.
25 (Dec. 10, 1948); see also History of the Document, UNrrED NATIONS (last visited Apr. 8, 2014), http://
www.un.org/en/documents/udhr/history/shtmi.
8 The Right to Health, supra note 3.
9 International Covenant on Economic, Social and Cultural Rights, G.A. Res. 2200A (XXI), U.N.
Doc. A/6316, at art. 12 (Dec. 16, 1966) [hereinafter Int'l Covenant on Econ., Soc. & Cultural Rts].
10 Universal Declaration of Human Rights, supra note 7, at art. 5; see also History of the Document,
supra note 7.
11 Universal Declaration of Human Rights, supra note 7, at art. 5; see also History of the Document,
supra note 7.
12 United States human rights activist, Eleanor Roosevelt was the driving force for the Declaration's
adoption. She produced a memoir about the drafting process, speaking about each nation's preferences
and beliefs. See History of the Document, supra note 7.
13 Universal Declaration of Human Rights, supra note 7, at art. 25.
14 History of the Document, supra note 7.
15 Universal Declaration of Human Rights, supra note 7, at art. 25.
16 Id.
17 Id.
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housing, and medical care, as well as the right to aid in the event of disability,
unemployment, sickness, or old age.i8
Possibly the most significant result of the UN's meetings throughout the 1940s
and the development of the Universal Declaration of Human Rights was the crea-
tion of the World Health Organization ("WHO") in 1948.19 All members of the
UN could become members of the WHO by signing or otherwise accepting its
Constitution.20 Through drafting and the subsequent process by which member
states signed the Constitution, all states effectively accepted that the highest at-
tainable standard of health is one of the fundamental rights of every human being
regardless of economic position. 21 In addition, contracting parties agreed to pro-
mote and protect the right to health for all people. 2 2 Substantively, the Constitu-
tion defines the right to health as "timely, acceptable, and affordable healthcare
of appropriate quality." 23 The Constitution further clarifies that all member states
must create conditions in their respective countries, in which everyone can be
healthy, namely by ensuring the availability of health services. 24 Article 20 of the
Constitution requires individual member states to take action toward acceptance
of WHO conventions or agreements within eighteen months of enactment. 25
Those that do not accept such conventions or agreements are required to provide
a written statement detailing their reasons. 26
The WHO and its Constitution require member states to make access to health
a priority at the national level, and yet several member states have signed and
accepted the Constitution without ratifying such documents or implementing the
components of a right to health at a national level. 27 Therefore, certain member
states reap the benefits of membership in the WHO, such as technical and policy-
based support, but only recognize a right to health as a progressive movement
some sixty years after the Constitution's acceptance. 2 8 In 2011, at the Executive
Board's 129th session, the WHO designed a method for reforming its structure
and organization to facilitate uniformity in global health and enable all member
18 Id.
19 History of WHO, WORML HEALTH ORG., http://www.who.int/about/history/en/ (last visited Apr.
10, 2014).
20 Countries, WORLD HEALTH ORG., http://www.who.int/countries/en/ (last visited Apr. 10, 2014)
(among the other 194 member states, France and the United States are members of the WHO and have
accepted the WHO Constitution at an international level).
21 Constitution of the World Health Organization ch. IV, July 22, 1946, 62 Stat. 6279, 14 U.N.T.S.
185, available at http://apps.who.int/gb/bd/PDF/bd47/EN/constitution-en.pdf.
22 Id.
23 The Right to Health, supra note 3; Constitution of the World Health Org., supra note 21, at art. 1.
24 The Right to Health, supra note 3.
25 Constitution of the World Health Org., supra note 21, at art. 1.
26 Id.
27 See Eleanor D. Kinney, The International Right to Health: What Does This Mean for Our Nation
and World?, 34 IND. L. Rrv. 1457, 1464 (2001) (as will be touched on later in the article, the United
States is among the member states who have not accepted the WHO Constitution at a national level).
28 See generally About WHO, WORLD HEAI.L:rH ORG., http://www.who.int/about/en/ (last visited Apr.
12, 2014); see also The Right to Health, supra note 3; see also Observations by the United States of
America on "The Right to Health, Fact Sheet No. 31," U.S. STATm DEPT 1,1 (Mar. 19, 2010).
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states to take a more active stance on universal care to its citizens and a right to
health for all people. 2 9
As a result of the WHO's development of an international right to health, the
UN passed the International Covenant on Economic, Social, and Cultural Rights
("ICESCR") in 1966, a human rights treaty that further defines the right to health
and creates steps for member states to realistically implement universal access to
care. 30 The ICESCR indicates that, in order to realize the highest attainable stan-
dard of health, member states must take steps to ensure access to the prevention,
treatment, and control of epidemics, as well as create conditions that allow all
citizens to seek medical attention in the event of illness.3 ' The UN Committee on
Economic, Social, and Cultural Rights, which monitors member states' compli-
ance with ICESCR, adopted General Comment 14 on the Right to Health in 2000
to provide clarity on Article 12 of the ICESCR and further define a right to
health, which includes timely and appropriate health care. 3 2 General Comment 14
indicates that the right to health is comprised of the availability and accessibility
of ethically acceptable health facilities, goods, and services. 33 The Committee
defines accessibility in physical terms, or access within safe reach, but also in
economic terms, meaning the requirement that health care is affordable for all. 34
General Comment 14 also indicates that all individuals are entitled to essential
drugs that will help to maintain their well-being. 35
While not all member states have fully realized their obligations under the
ICESCR on a national level, they are required by General Comment 14 to make
progression toward a national right to health; therefore, member states are called
to expeditiously utilize maximum available resources and make calculated steps
toward universal health care. 36 General Comment 14 also uses a three-tier ap-
proach to outline member states' obligations under the ICESCR. 3 7 It obligates
member states to: (1) refrain from interfering with citizens' right to health or
limiting equal access to care; (2) protect their citizens' from third party interven-
tion with citizens' right to health by adopting legislation which ensures equal
29 WHO Reform, WORuo HEALTH ORG., http://www.who.int/about/who-reform/en/ (last visited Apr.
12, 2014).
30 See generally Int'l Covenant on Econ., Soc. & Cultural Rts., supra note 9; see also The Right to
Health, supra note 3.
31 Int'l Covenant on Econ., Soc. & Cultural Rts., supra note 9, at art. 12; see also The Right to Health,
supra note 3.
32 United Nations, Econ. & Soc. Council, Comm. on Substantive Issues Arising in the Implementa-
tion of the Int'l Covenant of Econ., Soc., & Cultural Rts., I1, E/C. 12/2000/4 (2000); see also The Right
to Health, supra note 3.
33 United Nations, Econ. & Soc. Council, supra note 32, 1 12; see also The Right to Health, supra
note 3.
34 United Nations, Econ. & Soc. Council, supra note 32, ¶ 12; see also The Right to Health, supra
note 3.
35 United Nations, Econ. & Soc. Council, supra note 32, ¶ 12; see also The Right to Health, supra
note 3.
36 United Nations, Econ. & Soc. Council, supra note 32, ¶ 30; see also The Right to Health, supra
note 3.
37 United Nations, Econ. & Soc. Council, supra note 32, ¶ 33.
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access to care in a private health care system and controls the marketing of
medicines by third parties; and (3) implement legislation to promote the right to
health and ultimately adopt a national policy for realizing the full right to
health.38
General Comment 14 also adopts the Alma-Ata Declaration of 1978, an inter-
national treaty, which indicates that governments have a responsibility to create
access to health such that people are able to maintain a socially and economically
productive lifestyle. 39 The Alma-Ata Declaration also calls for international co-
operation to ensure primary care to all individuals because "the attainment of
health by people in any one country directly concerns and benefits every other
country."'40 Perhaps most significantly, General Comment 14 differentiates some
member states' inability to progress toward universal health care from other
states' unwillingness to do so. 4 1 General Comment 14 goes on to declare that a
member state's unwillingness to use its maximum resources to realize a right to
health for its citizens is in violation of its obligations under Article 12 of the
WHO constitution. 42
III. Discussion
The right to health and access to lifesaving care may play significant roles in
the global economy due to cancer's affect on citizens' social and economic pro-
ductivity and cancer treatments' impact on a citizen's financial standing. First,
this section will discuss the global implications of cancer both in a social and
economic capacity. Second, this section will discuss proposals for access to pri-
mary care, as well as prevention and detection mechanisms to reduce prevalence
and costs. Third, this section will discuss the various world health organizations
that are seeking reform in the treatment of cancer, in order to reduce the global
economic burden. Lastly, this section will discuss a specific example of the cost
of cancer drugs and the anomaly it presents.
It is arguably in a country's best interest to protect its citizens' right to health
and adopt programs related to cancer prevention and treatment, in an effort to
reduce the cost of cancer at a macroeconomic and microeconomic level. In devel-
oped nations, cancer is currently the leading cause of death, and it is the second
leading cause of death in developing nations after heart disease. However, ex-
perts at the World Health Organization project that cancer could soon be the
leading cause of death worldwide. 43 In 2008, there were approximately 4.8 mil-
38 Id.
39 See generally World Health Org., Declaration of Alma-Ata, International Conference on Primary
Health Care, USSR, Sept. 6-12, 1978, U.N. Doc. A56/27 (1978) [hereinafter W.H.O., Declaration of
Alma-Ata] (134 health ministries signed the Alma-Ata Declaration, which focused on the importance of
universal primary care for all individuals).
40 W.H.O., Declaration of Alma-Ata, supra note 39 at art. IX; see also United Nations, Econ. & Soc.
Council, supra note 32, T 38.
41 United Nations, Econ. & Soc. Council, supra note 32, ¶ 47; The Right to Health, supra note 3.
42 United Nations, Econ. & Soc. Council, supra note 32, 1 47.
43 Global Cancer Facts & Figures, AM. CANCER Soc'y, 2d ed. 1, I (2008), http://www.cancer.org/
acs/groups/content/@epidemiologysurveilance/documents/document/acspc-027766.pdf.
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lion cancer deaths in developing countries, as well as 2.8 million in developed
countries, with the number of deaths estimated to increase due to aging popula-
tions and western habits like smoking and physical inactivity. 4
The American Cancer Society and LIVESTRONG published the first study
quantifying the global economic cost of cancer in 2010, and the study showed
that cancer has the greatest economic impact from premature death and disability
of all causes of death worldwide. The economic cost of heart disease, the second
leading global cause of death, trails cancer by nearly 20%.45 Using data collected
from the WHO, the study estimated the number of life years lost due to death and
disability across seventeen types of cancer and the top fifteen leading causes of
death-the variable would become known as the "DALY" (disability-adjusted life
year). 46 In order to account for income disparities across the globe, the study
grouped countries into four income brackets and measured the economic value of
a year of healthy life in an attempt to measure the corresponding economic loss
due to death and illness.4 7 It was estimated that 83 million years of healthy life
were lost due to death and disability from cancer in 2008.48
By measuring indirect costs due to cancer such as loss of economic output due
to missed days at work and premature death, and without measuring direct costs
like dollars spent on treatment and rehabilitation, it was estimated that the total
cost of cancer worldwide was $895 billion in 2008.49 In sum, the indirect cost of
cancer was approximately 1.5% of the world's gross domestic product.5 o While
the data focuses on the economic impact across the globe, low-to-middle income
families are significantly burdened because loss of income due to disability or
death in the family takes a more significant toll on their annual income and abil-
ity to meet other financial obligations than it does on wealthier families.5 '
Furthermore, evidence suggests that even though the technology exists to de-
tect, prevent, and treat forms of cancer, the disease will not be successfully eradi-
cated until access to preventative care is increased. 5 2 National policies focused on
access to preventative measures, early detection, and quality treatment could sig-
nificantly increase the proportion of cancer detection and decrease cancer deaths,
44 Id.
45 THE GLOBAL ECONOMIC COST OF CANCER, supra note 5, at 1; see also Zosia Chustecka, Cancer
Has Greater Impact Than All Other Diseases, MEDSCAPE MED. NEWS (Aug. 25, 2010), http://www.med-
scape.com/viewarticle/727459.
46 THE, GLOBAL ECONOMIC COST OF CANCER, supra note 5, at 7.
47 Id.
48 Id. at 6.
49 THE GLOBAL ECONOMIC CosT OF CANCER, supra note 5, at 2; see also Chustecka, supra note 45;
see also Global Cancer Facts & Figures, supra note 43, at 9.
50 THE GLOBAL.. ECONOMIC COST OF CANCER, supra note 5, at 6; see also Chustecka, supra note 45.
51 See generally THE GLOAL ECONOMIC COST OF CANCER, supra note 5, at 1; see also Chustecka,
supra note 45.
52 Cancer Costs Projected to Reach At Least $158 Billion in 2020, NAT'L CANCER INST. (Jan. 12,
2011), cancer.gov/newscenter/newsfromnci/201 1/costcancer2020; see also Cancer Health Disparities,
NAT'L CANCER INST, http://www.cancer.gov/newscenter/newsfromnci/201 /CostCancer2020 (last up-
dated March 11, 2008) (the Center to Reduce Cancer Health Disparities is a National Cancer Institute
initiative aimed at researching and reducing health disparities).
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which will in effect reduce the global economic cost of cancer. 53 As a policy
matter, primary prevention is the most cost effective strategy for controlling the
spread of cancer, by identifying and eliminating exposure to cancer-causing fac-
tors such as tobacco use, poor nutrition, physical inactivity, occupational expo-
sures, and chronic infections. 54 Monitoring preventable forms of cancer could
make an especially noteworthy difference in low-to-middle income nations, as
many do not currently have preventative resources, and therefore, have the high-
est rates of preventable cancers in the world.55
For instance, death due to cervical cancer, a form of cancer which can be
diagnosed and treated with early detection, is significantly more prevalent in low-
to-middle income nations due to lack of access to prevention and detection mea-
sures.56 The access and incidence of pap testing, the detection mechanism for
cervical cancer, was higher in the 1960s in the United States than the highest
rates found today in Eastern Africa.57 The lack of resources to treat cancer and
the focus on communicable diseases in Africa creates a regulatory atmosphere
where cancer is of low public health priority, and as a result, African cancer
patients simply do not have access to preventative care.58
Several international organizations have recently gathered to call attention to
the rising incidence of cancer and implement policies focused on improved treat-
ment, prevention, early detection, and screening. The WHO addressed the global
burden of cancer in its 58th World Health Assembly in 2005, where member
states approved a resolution calling for improved cancer prevention and treat-
ment.59 Specifically, the resolution calls member states to increase access to care
by forming national cancer programs, which will increase early detection and
screenings, as well as improve palliative treatment.60 In addition, at the World
Cancer Congress in 2006, the global cancer community addressed the growing
global cancer burden and launched the first World Cancer Declaration, which
outlined the necessary steps to begin to reverse the global cancer crisis by 2020.61
However, the World Health Assembly extended the timeline for cancer control
from 2020 to 2025 at a meeting of member states in 2013.62 The member states
set out nine targets for cancer prevention and control in 2013, four of which
53 See Global Cancer Facts & Figures, supra note 43, at 9; see also Chustecka, supra note 45.
54 See Global Cancer Facts & Figures, supra note 43, at 3-4, 9; see also Chustecka, supra note 45.
55 See Global Cancer Facts & Figures, supra note 43, at 9, 37-38.
56 See id. at 9, 38-40.
57 Id. at 41.
58 Id. at 37.
59 World Health Assembly Res. 58.22/1, Cancer Prevention and Control, 58th Sess., May 25, 2005;
see also The 58th World Health Assembly Adopts Resolution on Cancer Prevention and Control, WORLD
HeALrn ORG., (May 25, 2005), http://www.who.int/mediacentre/news/releases/2005/pr_whaO5/en/.
60 World Health Assembly Res. 58.22/1, Cancer Prevention and Control, supra note 59; see also The
58th World Health Assembly Adopts Resolution on Cancer Prevention and Control, supra note 59.
61 Cary Adams et al., The World Cancer Declaration: From Resolution to Action, 12 LANCET ON-
coiLoGY 1091-92 (2011); see generally World Cancer Declaration, UNION FOR INTERNATIONAL CANCER
CONTROL, (2013), http://www.uicc.org/world-cancer-declaration.
62 Adams et al., supra note 61; see also World Cancer Declaration, supra note 61.
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specifically address access to care including: (1) universal coverage of HPV vac-
cination, (2) universal access to screening and early detection, (3) improving ac-
cess to diagnosis and treatment, and (4) universal availability to essential drugs
and pain control. 63 The revised World Cancer Declaration of 2013 specifically
addresses the need for international organizations to reinforce the human rights
established by the ICESCR to expand access to cancer prevention, detection, and
treatment methods. 64
There is an argument that the high cost cancer patients must pay for treatment
reflects the cost of developing cancer treatments, and thus, lowering costs will
hinder cancer research and development-particularly in the pharmaceuticals in-
dustry.65 Still, the rising costs seem unwarranted and continue to reduce access
to lifesaving treatments. For example, the drug Gleevec, used to treat chronic
myeloid leukemia ("CML"), entered the United States market in 2001 at approxi-
mately $30,000 a year, which was intended to reflect and cover the costs of
research and development. 66 After ten years on the market and faced with com-
petition from five newer drugs, the price has tripled.6 7 The developer of Gleevec,
Novartis, justifies its pricing by suggesting that few patients pay the full cost and
the current price of the drug reflects the high cost of research, as well as the value
of the drug to patients.68 However, doctors and researchers specializing in mye-
loid leukemia are now speaking out against drug developers like Novartis. 69 In an
article for Blood, the Journal for the American Society of Hematology, the CML
specialists suggested that charging an unreasonable price for lifesaving medicine
is essentially profiteering and similar to increasing prices of necessary supplies to
isolated communities in times of natural disasters. 70 The majority of the CML
experts indicated that the price of CML drugs might compromise patients' imme-
diate access to treatment that is proven to be effective for their disease and may
be their only option for remission.7' The article indicates that the increasing cost
of Gleevec reflects the rising cost of cancer drugs across the board. 72 In fact, of
the twelve cancer drugs approved by the Food and Drug Administration for dis-
tribution in 2012, eleven cost more than $100,000 a year, which is twice the
63 Id.
6 Id.
65 See generally The Cost of Cancer, NAT'L CANCER INST., http://www.cancer.gov/aboutnci/serv-
ingpeople/understanding-burden/costofcancer (last updated Nov. 2011); see generally Camille Abboud et
al., Price of Drugs for Chronic Myeloid Leukemia (CML), Reflection of the Unsustainable Cancer Drug
Prices: Perspective of CML Experts, 121 BLoon J. AM. Soc'Y OF HEMATOLOGY 4439, 4439 (2013).
66 Andrew Pollack, Doctors Blast Cost of Cancer Treatment, Bos. GLOBE, Apr. 26, 2013; see also
Abboud et al., supra note 65, at 4439.
67 Pollack, supra note 66; see also Abboud et al., supra note 65, at 4440.
68 Pollack, supra note 66; see also Abboud et al., supra note 65, at 4440.
69 Pollack, supra note 66; see generally Abboud et al., supra note 65.
70 Pollack, supra note 66 (Profiteering is the act of making excessive profits on goods which are in
short supply. Most types of profiteering is illegal; however, legalities differ from nation to nation.); see
also Abboud et al., supra note 65, at 4440.
71 Abboud et al., supra note 65, at 4439.
72 Id.
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figures for 2002.73 The doctors and researchers are calling for dialogue on lower-
ing pharmaceutical costs to increase access to care, which they say will save
patient's lives. 74
IV. Analysis
Instituting a right to health at a national level could lead to greater access to
health care for individuals, including preventative services and increased treat-
ment options for cancer patients, as well as better health outcomes.75 At an indi-
vidual patient level, instituting a right to health could mean access to lifesaving
treatments for cancer patients. At a governmental and macroeconomic level, in-
stituting a right to health and guaranteeing access to preventative services and
treatment options for cancer patients could result in reducing the global economic
cost of cancer.76 till, the right to health is not implemented at a national level
worldwide.77 In a study performed by the Global Public Health Journal in 2013,
researchers found that, out of 191 countries in the UN, only 36% guaranteed the
right to overall health in their individual constitutions.78 The French and Ameri-
can health care systems have different approaches to the right to health and the
following section will discuss how such rights, or lack thereof, impact access to
care and cancer costs in the respective countries.
A. France
By signing and accepting the WHO Constitution and further defining the right
to health through ratification of the ICESCR, a treaty with one of the most devel-
oped definitions of the right to health, France recognizes that all of its citizens
have the right to the highest attainable standard of health.79 Accordingly, the
French health care system has undertaken the obligation to use maximum re-
sources to realize a right to health for all citizens.80 In doing so, the French
73 Id.
74 Pollack, supra note 66 (the doctors have not studied other cancer drugs, but merely discuss the
negative impact of the price of Gleevec on their patients.); see also Abboud et al., supra note 65, at 4441.
75 See Joanna N. Erdman, Human Rights in Health Equity: Cervical Cancer and HPV Vaccines, 35
AM. J.L. & MED. 365, 386 (2009); see generally Kinney, supra note 27, at 1457; see generally Jody
Heymann et al., Constitutional Rights to Health, Public Health and Medical Care: The Status of Health
Protections in 191 Countries, 8 Global Pub. Health: An Int'l J. for Research, Policy and Practice 639,
651-52 (2013); see generally Claire Andre & Manuel Velasquez, System Overload: Pondering the Ethics
of America's Health Care System, 3 Issuos IN ETHics 3, 3 (1990); see also Hiroaki Matsuura, The Effect
of a Constitutional Right to Health on Population Health in 157 Countries, 1970-2007: the Role of
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government focuses its health care system on its patient.8 ' As a result, citizens
consider access to health an inherent right, and the public becomes defensive
when that right is threatened. 8 2
In 2000, the WHO performed a study on the world's health care systems and
ranked each nation based on variables such as the number of years people lived
in good health and whether everyone in the country had access to quality health
care. 8 3 France ranked first among 191 countries, while the United States ranked
thirty-seventh. 8 4 Arguably, France ranks higher than the United States because
the French government has done a better job protecting liberty, equality, and
human rights in its social programs including health care.85 Every citizen in
France has a right to care and every person is insured. 86 In fact, the sicker one is
in France, the more his health care costs are covered; thus, the sickest patients in
France, including cancer patients, are exempt from co-payments and need not
worry about going bankrupt over medical bills. 8 7 Furthermore, the government
pays for cancer patients' health care costs, surgeries, therapies, and drugs.88
In addition, French citizens can choose any doctor for treatment, and doctors
can choose any drug or treatment they believe best fits the patient notwithstand-
ing the cost.89 Therefore, cancer patients rarely discuss costs of cancer treatments
with their doctors. 90 Instead, according to Dr. Fabian Calvo, deputy director of
France's National Cancer Institute, the French government has made all cancer
drugs available to patients, including the most expensive and experimental. 9 '
Therefore, doctors can choose drugs that will prolong patients' lives without wor-
rying about barriers like costs. 9 2
In order to fund the single government-run health insurer, French taxpayers
pay premiums based on a percentage of their salaries. 93 Therefore, costs for
81 David Gauthier-Villars, France Fights Universal Care's High Costs, WALL Sr. J., Aug. 7, 2009,
http://online.wsj.com/news/articles/SBl24958049241511735; see also General National Patient Rights
Protection, CTR. FOR BIOMED. ETHICS & L., http://europatientrights.eu/countries/signed/france/france
.html (last updated 2008).
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83 Joseph Shapiro, Health Care Lessons From France, NAT'L Pun. RADIO (July I1, 2008), http://
www.npr.org/templates/story/story.php?storyld=92419273; Health Systems: Improving Performance,
The World Health Report 2000, WORLD HEALTH ORG., WA 540, 1, 152 (2000).
8 Shapiro, supra note 83; see also Health Systems: Improving Performance, supra note 83, at 153,
155.
85 Shapiro, supra note 83; see also Health Systems: Improving Performance, supra note 83, at xiv.
86 Shapiro, supra note 83; see also Health Systems: Improving Performance, supra note 83, at xiv
(French citizens pay taxes out of their income to fund the government health care system).
87 Shapiro, supra note 83.
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89 Timothy Stoltzfus Jost, Diane Dawson & Andre den Exter, The Role of Competition in Health
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health insurance are relative to citizens' income and are based on citizens' ability
to pay. 9 4 It can be argued that the seemingly successful French health care system
is not "cheap." 95 Still, it is not as expensive as the U.S. system, which is the
most expensive in the world. 96 For example, in 2011, the total U.S. health care
expenditure per capita was $8,608, while total French health care spending per
capita was $4,086.97 In addition, the United States spends $606 per person on
administrative insurance costs, while France, through its government-run insurer
pays only $277 per person.9 8 The U.S. may argue that French citizens are re-
quired to pay much more than Americans because 21% of a citizen's income in
France goes toward the national health care system, which is significantly higher
than U.S. citizens' contribution. 9 However, U.S. citizens must consider what
they are getting for their money. While they pay much less out of their paychecks
for health insurance, the out-of-pocket expenses for medicine, doctors, and hospi-
tals in the event of a serious ailment will quickly rise above what the French are
paying.'" In sum, the French government recognizes that its citizens have the
right to the highest attainable standard of health and thus, ensures access to care
and lifesaving care for cancer patients despite cost.
B. The United States
To the contrary, the United States does not recognize a right to health for its
citizens.10 ' In a report produced by the State Department, the U.S. explicitly cate-
gorized the obligations in the WHO Constitution and ICESCR as progressive
goals, rather than present obligations.' 0 2 In doing so, the U.S. has effectively
accepted the WHO's Constitution at an international level, but has not imple-
mented its standards of health care in U.S. policy, nor accepted or ratified the
ICESCR. 0 3 Rather, the State Department argues that it has no obligation to enact
any laws pertaining to the WHO Constitution and that the WHO Constitution has
no authority in the U.S.104 Furthermore, the State Department does not guarantee
94 Id.
95 Shapiro, supra note 83.
96 Id.
97 France, WORDio HEAL PH ORG., http://www.who.int/countries/fra/en/ (last visited Apr. 1, 2014);
United States, WORLo HEALTH ORG., http://www.who.int/countries/usa/en (last visited Apr. 1, 2014);
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2013), http://www.upi.com/HealthNews/2013/11/13/US-healthcare-Most-expensive-longest-waits-
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any specific right to health in the United States-a stance that is quite outdated
and inefficient compared to the global community's stance.105
The American Cancer Society has indicated that "lack of health insurance and
barriers to care prevent many Americans from getting good, basic [cancer treat-
ment]."l0 6 In that regard, citizens in the US pay an exuberant amount for health
insurance, which inevitably results in fewer insured citizens and decreased access
to lifesaving care.10 7 Contrary to the French health care system, before 2014, the
United States did not require that individuals have health insurance and did not
provide universally accessible public programs for citizens. 0 8 Rather, 62% of
U.S. citizens received employer-sponsored health insurance, 15% were enrolled
in public health insurance, and 18% were uninsured.1 09 Furthermore, in the
United States health care system, employers pay citizens' premiums, but citizens
are required to pay all out-of-pocket costs like co-payments and direct costs to
the provider for services, which can quickly rise to the tens or hundreds of
thousands of dollars for cancer patients."10 In the United States, 44% of health
spending is funded by government revenue, which is well below the global aver-
age of 72% in developed nations." 1 Lastly, the United States is one of the most
inefficient health care countries in the world. Despite being the richest nation in
the world, the United States ranks 46th out of 48 for health care efficiency, while
France ranks 19th out of 48.112
Moreover, private costs for serious ailments like cancer fall directly on the
patient in the United States, and out-of-pocket costs add up quickly." 3 For in-
stance, U.S. patients are typically required to pay a 25% co-payment for cancer
drugs that cost thousands of dollars a month-all of which is due at the time the
drugs are administered and cannot be paid on a monthly plan.' '4 Furthermore,
patients often feel unsure asking about costs and payment options upfront, as
they are worried it will affect the type of care they receive." 5 This is signifi-
cantly different from the ideology in France, where patients and doctors do not
worry about the costs associated with treatment and only focus on the best out-
105 Id. at 3-4.
106 Economic Impact of Cancer, AM. CANCER Soc'Y, http://www.cancer.org/cancer/cancerbasics/eco-
nomic-impact-of-cancer (last visited Apr. 3, 2014).
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come. 16 Historically, U.S. patients have not had the flexibility that French pa-
tients have in choosing the best doctors, treatments, or drugs because patients in
the U.S. are limited by costs and often settle for the cheaper, less recommended
options.' 17 In addition, uninsured patients and those from ethnic minorities have
less access to preventative and diagnostic services related to cancer, leading to
higher rates of diagnosis at a later stage in their cancer and, inevitably, a more
costly treatment and poorer health results.' 1 8
Although the U.S. has largely refuted the global standard of a right to health,
the recently adopted Patient Protection and Affordable Care Act ("ACA") shows
a positive step in expanding access to care for cancer patients. With the United
States' roll out of the ACA in late 2013 to early 2014, the government intends to
increase coverage for those who are currently uninsured.' 1 9 The ACA also strives
to create a statutory right to health for American cancer patients and those at risk
for cancer by ensuring coverage for pre-existing conditions like cancer, ensuring
the right to choose a doctor, and enhancing access to preventative services.1 20
However, recent reports have indicated that the top hospitals for cancer treatment
are "off-limits" for newly insured cancer patients under the ACA, which ex-
pressly contradicts the right to treatment promised to such patients.1 2 1 Whether or
not the rights provided by the ACA will become a constitutional right to health
remains to be determined as the ACA is implemented and cancer patients and
those at risk begin to benefit from its rights. 122 There is arguably still a need for a
greater push toward a right to health.1 23
V. Proposal
The right to health care, specifically access to cancer care, should not be com-
promised for the American people because of the costs and inefficiencies of the
American health care system. From an international human rights perspective, it
is difficult to understand why French cancer patients have a right to treatment at a
reasonable price, but most American cancer patients do not realize the same cost
116 Walsh, supra note 90.
117 The Cost of Cancer Treatment, supra note 113; The Health Care Law, How it Can Help People
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for treatment or any treatment at all. 1 2 4 Dr. Nils Wilkin, a clinical oncologist at
the Karolinska Institute in Stockholm, wrote a report on the disparities in cancer
treatments based on geographic region and found that "where you live can deter-
mine whether you receive the best treatment or not."l 2 5 The global right to health
cannot be said to exist while people are denied equal access to existing, lifesav-
ing technology simply because of their geographic location. There is an interna-
tional human rights issue at stake, and global health leaders should be called to
evaluate whether citizens in comparable countries are being treated equally in the
administration of lifesaving treatments. Additionally, in an attempt to reduce the
global economic cost of cancer, it is in the best interest of international leaders to
put pressure on developed nations like the United States to institute a right to
health nationally and increase access to lifesaving care.
While the United States has accepted the WHO Constitution, it has failed to
implement a right to health on a national level and refuses to take on the height-
ened responsibilities created by the ICESCR.1 26 The Constitution expressly states
that, "governments have a responsibility for the health of their peoples which can
be fulfilled only by the provision of adequate health and social measures."1 2 7
Furthermore, the ICESCR distinguishes a country's inability to institute a na-
tional right to health from a country's unwillingness.1 2 8 If a country is simply
unwilling to use its maximum resources to realize a right to health, the country is
in violation of Article 12 of the ICESCR.1 29
Yet, in the United States' response to the Right to Health Fact Sheet, No. 31
issued by the World Health Organization, the State Department firmly declares
that, while the United States has accepted the WHO Constitution, it did so with
the understanding that it is under no obligation to enact specific legislation based
on the Constitution.1 3 0 The State Department reiterates that it has no obligation to
meet the requirements set forth in the ICESCR because the United States is not
forced to ratify the document.' 3 ' Thus, the State Department indicates that the
United States has no international obligation to "respect, protect, and fulfill the
'right to health' to individuals." 3 2 By expressly dismissing its responsibility to
meet the obligations set forth in the Constitution and the ICESCR, the United
124 The Cost of Cancer Treatment, supra note 113; see also Walsh, supra note 90.
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States is allowing the gaps between the rich and the poor and the inequality in
international human rights among classes to widen tremendously. 133
UN treaty-monitoring committees like the Committee on Economic, Social
and Cultural Rights, as well as international judicial institutions, should be called
to discuss whether the United States' refusal to acknowledge the right to health
directly correlates with its cancer patients' poor access and affordability of life-
saving treatments.1 34 In addition, such international leaders should question
whether the United States, the wealthiest nation in the world, is in violation of its
obligations under the WHO Constitution and the ICESCR.1 35 By allowing hospi-
tals to close their doors to cancer patients seeking lifesaving treatment, even
though American hospitals have the technology and resources to treat patients,
the United States is standing in the way of its citizens' international right to the
highest attainable standard of health. In addition, among the likes of Cuba and
Belize, the United States is one of only six countries that have yet to ratify the
ICESCR on a national level some thirty years after signing it.136 The Committee
on Economic, Social and Cultural Rights should define the barriers that prohibit
the United States from abiding by and ratifying the ICESCR obligations. There-
after, the Committee must determine whether the potential social and economic
benefits, including increased access to lifesaving treatment and the decreased ec-
onomic burden of cancer, derived from obliging with the ICESCR outweigh the
cost of eliminating such barriers.
Furthermore, the United States arguably has a heightened responsibility to care
for cancer patients due to the agreements made in the World Cancer Declaration
of 2006 and 2013.137 Member states, including the U.S. and France, set out nine
targets for cancer prevention and control, four of which focused on access to care
issues.' 38 The World Cancer Congress and the World Health Assembly were
particularly concerned with the early detection and prevention of cancer.1 3 9 How-
ever, in a country where medical care and health insurance is so costly, it is
unlikely that all cancer patients will be able to access detection or prevention
services. Thus, it could be argued that countries like the U.S., which have failed
to cover multitudes of preventative medicine in its health insurance plans and
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have not significantly increased access to preventative measures, are in violation
of the World Cancer Declaration.1 4 0
While the ACA aims to increase accessibility to preventative and detection
services, it will take some time to determine whether cancer patients and those at
risk of cancer are actually experiencing increased access to affordable services.
There are already reports that hospitals are turning away cancer patients and
those at risk of cancer, even after the 2014 ACA enrollment period, because they
do not accept the patients' new health insurance.141 Therefore, national and inter-
national leaders should be called to re-analyze countries' obligations under the
World Cancer Declaration and enforce such obligations where necessary, in or-
der to meet the World Cancer Congress' goal of reversing the burden of cancer
by 2025.142
Through enforcement measures by treaty-monitoring committees and the
World Cancer Congress, the social effects and the economic costs of cancer can
be reversed. If the United States is not willing to consider its cancer patients'
quality of life as the sole reason for improving access to lifesaving treatment,
perhaps the potential money saved will sway the government in enforcing poli-
cies focused on the right to health. National policies focused on access to pre-
ventative measures, early detection, and quality treatment are the most cost-
effective strategies and could significantly increase the proportion of cancer de-
tection and decrease death due to cancer.1 43 As a result, a right to health and
increased access to cancer treatment will decrease low productivity levels due to
death and disability, which will ultimately improve the United States'
economy.1 4 4
VI. Conclusion
Based on economic and epidemiologic research, it is in the best interests of the
international community to focus on global policy guaranteeing access to lifesav-
ing treatments for cancer patients. Not only will the global economic cost of
cancer be reduced or possibly reversed, but patients across the globe will finally
have the right to health despite geographic location. On a nation-by-nation basis,
the technology exists to detect, prevent, and treat cancer; however, the disease
will not be eradicated until access to care is increased. International governments
should put more pressure on resourceful nations across the globe to institute a
national right to health modeling the rights in countries that already guarantee
universal access to care and do not turn away cancer patients seeking access to
lifesaving treatment.
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